Russell Investments Group Ltd. raised its stake in shares of Varex Imaging Co. (NASDAQ:VREX - Free Report) by 510.7% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 471,612 shares of the company's stock after acquiring an additional 394,381 shares during the quarter. Russell Investments Group Ltd. owned approximately 1.14% of Varex Imaging worth $6,881,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds also recently made changes to their positions in the company. Isthmus Partners LLC raised its holdings in shares of Varex Imaging by 0.8% in the fourth quarter. Isthmus Partners LLC now owns 149,874 shares of the company's stock valued at $2,187,000 after buying an additional 1,260 shares during the last quarter. Inspire Advisors LLC lifted its position in shares of Varex Imaging by 22.5% during the fourth quarter. Inspire Advisors LLC now owns 17,334 shares of the company's stock worth $253,000 after purchasing an additional 3,185 shares in the last quarter. New York State Common Retirement Fund grew its stake in shares of Varex Imaging by 60.7% during the fourth quarter. New York State Common Retirement Fund now owns 9,531 shares of the company's stock valued at $139,000 after purchasing an additional 3,600 shares during the last quarter. Principal Financial Group Inc. increased its holdings in shares of Varex Imaging by 10.5% in the fourth quarter. Principal Financial Group Inc. now owns 41,144 shares of the company's stock valued at $600,000 after purchasing an additional 3,914 shares in the last quarter. Finally, Geode Capital Management LLC lifted its holdings in Varex Imaging by 0.5% during the 3rd quarter. Geode Capital Management LLC now owns 929,004 shares of the company's stock worth $11,076,000 after buying an additional 4,211 shares in the last quarter.
Insider Transactions at Varex Imaging
In other news, SVP Kimberley E. Honeysett sold 4,007 shares of the firm's stock in a transaction dated Thursday, March 20th. The stock was sold at an average price of $12.81, for a total transaction of $51,329.67. Following the sale, the senior vice president now owns 4,002 shares of the company's stock, valued at $51,265.62. This trade represents a 50.03 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Sunny Sanyal sold 8,749 shares of the stock in a transaction that occurred on Wednesday, April 2nd. The stock was sold at an average price of $11.24, for a total value of $98,338.76. Following the sale, the chief executive officer now directly owns 190,193 shares of the company's stock, valued at approximately $2,137,769.32. The trade was a 4.40 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 4.30% of the company's stock.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently weighed in on VREX shares. Oppenheimer dropped their target price on Varex Imaging from $30.00 to $23.00 and set an "outperform" rating for the company in a research report on Friday, February 7th. B. Riley restated a "buy" rating and set a $22.00 target price (up from $21.00) on shares of Varex Imaging in a research report on Friday, February 7th. Finally, StockNews.com raised shares of Varex Imaging from a "hold" rating to a "buy" rating in a research note on Friday, February 7th.
Get Our Latest Research Report on VREX
Varex Imaging Trading Down 3.3 %
Shares of NASDAQ:VREX traded down $0.26 during midday trading on Tuesday, hitting $7.63. The company had a trading volume of 454,724 shares, compared to its average volume of 557,221. The company has a current ratio of 4.36, a quick ratio of 2.50 and a debt-to-equity ratio of 1.02. Varex Imaging Co. has a 12 month low of $7.30 and a 12 month high of $17.46. The firm has a fifty day simple moving average of $11.84 and a 200 day simple moving average of $13.22. The stock has a market cap of $314.36 million, a price-to-earnings ratio of -6.52 and a beta of 0.65.
Varex Imaging (NASDAQ:VREX - Get Free Report) last issued its earnings results on Thursday, February 6th. The company reported $0.07 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.04 by $0.03. Varex Imaging had a positive return on equity of 4.00% and a negative net margin of 5.79%. On average, analysts predict that Varex Imaging Co. will post 0.53 EPS for the current year.
Varex Imaging Profile
(
Free Report)
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.
Further Reading

Before you consider Varex Imaging, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Varex Imaging wasn't on the list.
While Varex Imaging currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.